On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Ionis Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Ionis Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Ionis Pharmaceuticals (United States)?

ScholarIQrecord summary

Ionis Pharmaceuticals (United States) is a research organisation in Carlsbad, US. OpenAlex records 3,631 works and 848,339 citations for it. 772 researchers list it as their most recent affiliation.

How many works does Ionis Pharmaceuticals (United States) have?

ScholarIQindexed works

Ionis Pharmaceuticals (United States) has 3,631 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Ionis Pharmaceuticals (United States) →

How many citations does Ionis Pharmaceuticals (United States) have?

ScholarIQcitation count

Ionis Pharmaceuticals (United States) has 848,339 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Ionis Pharmaceuticals (United States) →

How many researchers are at Ionis Pharmaceuticals (United States)?

ScholarIQresearcher count

Ionis Pharmaceuticals (United States) has 772 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Ionis Pharmaceuticals (United States)?

ScholarIQavg h-index

Ionis Pharmaceuticals (United States) has an average h-index of 58.8 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Ionis Pharmaceuticals (United States)?

ScholarIQror

The ROR for Ionis Pharmaceuticals (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Ionis Pharmaceuticals (United States)?

ScholarIQopenalex

The OpenAlex for Ionis Pharmaceuticals (United States) is on the source record.

Open the OpenAlex →

What is the Wikidata of Ionis Pharmaceuticals (United States)?

ScholarIQwikidata

The Wikidata for Ionis Pharmaceuticals (United States) is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Ionis Pharmaceuticals (United States)?

ScholarIQtop researchers by citations

Brett P. Monia · Amyloidosis: Diagnosis, Treatment, Outcomes

415 works30,539 citations

Susan M. Freier · DNA and Nucleic Acid Chemistry

149 works20,582 citations

Frank Rigo · RNA Research and Splicing

249 works20,446 citations

Aaron Yarlas · Inflammatory Bowel Disease

132 works1,820 citations

What are the most-cited papers on Ionis Pharmaceuticals (United States)?

ScholarIQmost cited works

The minimally important difference of the Asthma Control Test

Michael Schätz, Mark Kosinski, Aaron Yarlas, Jennifer Hanlon, Maria Watson, Priti Jhingran

Journal of Allergy and Clinical Immunology. 2009562 Citations

Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis

Tania F. Gendron, Jeannie Chew, Jeannette N. Stankowski, Lindsey R. Hayes, Yong‐Jie Zhang, Mercedes Prudencio, Yari Carlomagno, Lillian M. Daughrity, Karen Jansen‐West, Emilie A. Perkerson, Aliesha D. O’Raw, Casey Cook, Luc Pregent, Véronique Belzil, Marka van Blitterswijk, Lilia J. Tabassian, Chris W. Lee, Mei Yue, Jimei Tong, Yuping Song, Monica Castanedes‐Casey, Linda Rousseau, Virginia Phillips, Dennis W. Dickson, Rosa Rademakers, John Denis Fryer, Beth Rush, Otto Pedraza, Ana M. Caputo, Pamela Desaro, Carla Palmucci, A. Robertson, Michael G. Heckman, Nancy N. Diehl, Edythe Wiggs, Michael Tierney, Laura Braun, Jennifer Farren, David Lacomis, Shafeeq Ladha, Christina Fournier, Leo McCluskey, Lauren Elman, Jon B. Toledo, Jennifer D. McBride, Cinzia Tiloca, Claudia Morelli, Barbara Poletti, Federica Solca, A. Prelle, Joanne Wuu, Jennifer Jockel‐Balsarotti, Frank Rigo, Christine Ambrose, Abhishek Datta, Weixing Yang, Denitza Raitcheva, Giovanna Antognetti, Alexander McCampbell, John C. van Swieten, Bruce L. Miller, Adam L. Boxer, Robert H. Brown, Robert Bowser, Timothy M. Miller, John Q. Trojanowski, Murray Grossman, James D. Berry, William T. Hu, Antonia Ratti, Bryan J. Traynor, Matthew D. Disney, Michael Benatar, Vincenzo Silani, Jonathan D. Glass, Mary Kay Floeter, Jeffrey D. Rothstein, Khrista Boylan, Leonard Petrucelli

Science Translational Medicine. 2017269 CitationsOPEN ACCESS

Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy

Wolfgang Sieghart, Doris Losert, Sabine Strommer, Daniel Cejka, Katharina Schmid, Susanne Rasoul‐Rockenschaub, Martin Bodingbauer, Richard Crevenna, Brett P. Monia, Markus Peck‐Radosavljevic, Volker Wacheck

Journal of Hepatology. 2005255 CitationsOPEN ACCESS

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

Julián Panés, Séverine Vermeire, James O. Lindsay, Bruce E. Sands, Chinyu Su, Gary S. Friedman, Haiying Zhang, Aaron Yarlas, Martha Bayliss, Stephen Maher, Joseph C. Cappelleri, Andrew G. Bushmakin, David T. Rubin

Journal of Crohn s and Colitis. 2017106 CitationsOPEN ACCESS

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder

Raymond W. Lam, François-Xavier Lamy, Natalya Danchenko, Aaron Yarlas, Michelle K. White, Benoît Rive, Delphine Saragoussi

Neuropsychiatric Disease and Treatment. 2018104 CitationsOPEN ACCESS

How much of the research on Ionis Pharmaceuticals (United States) is open access?

ScholarIQopen access share

67%OPEN ACCESS

Gold

25%

Green

Hybrid

17%

Bronze

25%

Closed

33%